Best Empliciti (Elotuzumab) Medicine in India

Empliciti (Elotuzumab) is a targeted immunotherapy used in combination with other medicines to treat multiple myeloma in adults whose disease has returned or has not responded adequately to previous treatments. It is a monoclonal antibody that targets SLAMF7, a protein found on multiple myeloma cells and certain immune cells, helping the immune system recognize and attack abnormal cancer cells.

Empliciti (Elotuzumab) is administered by a healthcare professional through an intravenous infusion. It is given in combination with other prescribed multiple myeloma treatments, and the dose and treatment schedule are determined by your doctor based on your condition and treatment response. Medicines may be given before the infusion to help reduce the risk of infusion-related reactions. Regular blood tests and medical check-ups may be required during treatment.

Common side effects of Empliciti (Elotuzumab) may include fatigue, fever, diarrhea, constipation, cough, sore throat, decreased appetite, weight loss, high blood sugar, and infusion-related reactions. Infections and changes in blood cell counts may also occur. Inform your doctor if any side effect becomes severe, persistent, or causes concern. Before starting treatment, tell your doctor about your medical conditions and all medicines, vitamins, herbal products, or dietary supplements you are taking.

Treatment of Multiple Myeloma

Empliciti (Elotuzumab) is used in combination with other medicines to treat multiple myeloma in adults whose cancer has returned or has not responded adequately to previous treatment. It targets SLAMF7, a protein found on multiple myeloma cells, and helps activate the immune system to recognize and destroy abnormal cancer cells. This targeted immunotherapy can help reduce myeloma cell levels, slow disease progression, and support better control of the cancer.

Some side effects of Empliciti (Elotuzumab) may improve as your body adjusts to the treatment. Consult your doctor if any side effect persists, becomes severe, or causes concern.

Common Side Effects of Empliciti (Elotuzumab)

Empliciti (Elotuzumab) is administered by a healthcare professional through an intravenous infusion. It is given in combination with other medicines used to treat multiple myeloma. The dose and treatment schedule are determined by your doctor based on your condition, treatment plan, and response to therapy. Medicines may be given before the infusion to help reduce the risk of infusion-related reactions. Regular medical check-ups and blood tests may be required during treatment.

Empliciti (Elotuzumab) works by targeting SLAMF7, a protein found on multiple myeloma cells and certain immune cells. By binding to SLAMF7, it helps activate the immune system, particularly natural killer (NK) cells, to recognize and destroy abnormal myeloma cells. This immune-based action helps reduce cancer cells and may slow the progression of multiple myeloma.

• Keep the medicine refrigerated at a temperature of 2°C to 8°C.
• Ensure the product is not exposed to freezing conditions.
• Shield the medicine from direct light during storage.
• Retain it in the original packaging until it is ready for use.

Alcohol CONSULT YOUR DOCTOR

Consult your doctor before consuming alcohol during treatment with Empliciti (Elotuzumab).

Pregnancy CONSULT YOUR DOCTOR

Empliciti (Elotuzumab) is used with other medicines that may harm an unborn baby. Inform your doctor if you are pregnant or planning to become pregnant.

Breastfeeding CONSULT YOUR DOCTOR

Breastfeeding is not recommended during treatment with Empliciti (Elotuzumab). Consult your doctor for guidance.

Driving CONSULT YOUR DOCTOR

Empliciti (Elotuzumab) may cause fatigue, dizziness, or infusion-related symptoms. Avoid driving if these effects affect your alertness.

Kidney CAUTION

Inform your doctor if you have kidney problems. Your doctor will determine the appropriate treatment and monitoring.

Liver CAUTION

Tell your doctor if you have liver problems. Liver function may be monitored during treatment with Empliciti (Elotuzumab).

• Attend all scheduled appointments and follow the complete treatment plan prescribed by your doctor.
• Inform your doctor immediately if you experience fever, chills, difficulty breathing, dizziness, rash, or swelling during or after the infusion.
• Attend regular blood tests to monitor blood cell counts, blood sugar levels, and your response to treatment.
• Inform your doctor about all medicines, vitamins, herbal products, and dietary supplements you are taking to help prevent possible interactions.
• Do not change, interrupt, or stop Empliciti (Elotuzumab) treatment without your doctor's advice.
• Read More About - Empliciti (Elotuzumab) from Pharma Five.

Pharma Five, can facilitate patients in importing Empliciti (Elotuzumab) in small quantities for personal medical use. The applicant is required to submit an application in Form 12A together with a prescription provided by a Registered Medical Practitioner (RMP).

With extensive pharmaceutical industry expertise, Pharma Five provides patients with professional assistance in accessing Empliciti (Elotuzumab) and other specialized medicines through the relevant import facilitation process. Pharma Five provides extensive pharmaceutical service coverage across India, serving patients and healthcare requirements in prominent cities such as Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.